Nukkleus Inc.

NasdaqGM NUKK

Nukkleus Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2024: USD -13.06 M

Nukkleus Inc. EBIT is USD -13.06 M for the Trailing 12 Months (TTM) ending June 30, 2024, a -14.36% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Nukkleus Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -11.42 M, a -83.22% change year over year.
  • Nukkleus Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -6.23 M, a -2,965.74% change year over year.
  • Nukkleus Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -203.34 K, a 56.51% change year over year.
  • Nukkleus Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2020 was USD -467.53 K, a 32.83% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Loading...
SV Wall Street
NasdaqGM: NUKK

Nukkleus Inc.

CEO Mr. Menachem Shalom
IPO Date March 4, 2015
Location United States
Headquarters 525 Washington Boulevard
Employees 12
Sector Finance
Industries
Description

Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers financial services to enable conversion of fiat currencies to cryptocurrencies and vice versa. The company was formerly known as Compliance & Risk Management Solutions Inc. and changed its name to Nukkleus Inc. The company was incorporated in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.

StockViz Staff

January 30, 2025

Any question? Send us an email